Genes and dyslipoproteinaemias

Area of Science:

• Cardiovascular Medicine
• Lipid Metabolism
• Genetics

Background:

• Low high density lipoprotein (HDL)-cholesterol is a significant predictor of coronary heart disease (CHD).
• Exogenous and genetic factors influence HDL-cholesterol levels.
• The apoprotein B/apo A-I ratio is a meaningful predictor of CHD risk in young myocardial infarction (MI) survivors.

Purpose of the Study:

• To investigate the role of apoprotein A-I (apo A-I) variants in low HDL-cholesterol levels and CHD risk.
• To determine the underlying mechanisms of HDL-cholesterol depletion and apo A-I deficiency.

Main Methods:

• Analysis of apo A-I variants in young MI survivors and controls.
• Comparison of apo B/apo A-I ratio with lipoprotein lipid ratio for CHD risk prediction.

Main Results:

• No increased prevalence of apo A-I variants was found in young MI survivors compared to controls.
• Apo A-I variants likely do not substantially contribute to low HDL-cholesterol or CHD risk in the general population.
• Genetic anomalies are more likely related to regulatory or catabolic events than structural apo A-I anomalies.

Conclusions:

• Low HDL-cholesterol is a key risk factor for CHD.
• Apo A-I variants are not a primary cause of low HDL-cholesterol or increased CHD risk.
• HDL-cholesterol homeostasis is regulated by complex genetic and metabolic factors.